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The implantation of joint prostheses, especially for 
the hip and knee, is becoming increasingly common. 
This provides a significant reduction in discomfort and 
an immeasurable improvement in patient mobility. Re-
views of the worldwide literature indicate that 1 to 5% 
of these prostheses become infected, although it is im-
portant to remember that as the number of operations 
performed to implant these prosthesis increases, so will 
the number of cases of this type of infection. Gram-
positive bacteria predominate in contaminations of joint 
prostheses, in particular Staphylococcus aureus and 
Staphylococcus epidermidis. Infections caused by gram-
negative bacilli and fungi such as Candida sp have been 
reported with increased frequency throughout the world. 
Infections of joint prostheses present characteristic signs 
that can be divided into acute manifestations (severe 
pain, high fever, toxemia, heat, redness and wound se-
cretions) and chronic manifestations (progressive pain, 
cutaneous fistula formation and pus drainage, without 
fever). The definitive diagnosis of the infection should 
be made through cultures to isolate the microorganism, 
using material collected from joint fluid puncture, sur-
gical wound secretions, and surgical debridement. It is 
essential to cover for methicillin-resistant Staphylococ-
cus aureus, given the epidemiological importance of this 
agent in these infections. The total duration of antibiotic 
therapy ranges from six weeks to six months, and this 
treatment should be adjusted as needed, based on the 
results from culturing.
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The implantation of joint prostheses, especially for 
the hip and knee, is becoming increasingly common. 
This provides a significant reduction in discomfort and 
an immeasurable improvement in patient mobility(1,2). 
It has been estimated that, including both primary and 
revision surgery, around 800,000 operations to implant 
hip and knee prostheses are performed every year, in 
the USA alone(3) (Figure 1). Furthermore, although in 
small numbers, implantations of joint prostheses for the 
shoulder, elbow, wrist and temporomandibular joint are 
also becoming more common(2). Reviews of the world-
wide literature indicate that 1 to 5% of these prostheses 
become infected, although it is important to remember 
that as the number of operations performed to implant 
these prosthesis increases, so will the number of cases 
of this type of infection(4) (Figure 2). Even though infec-
tion occurs less frequently than mechanical loss of the 
prosthesis, it is considered to be the most devastating of 
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Adapted from: Kurtz et al(3).
&IGURE  n Evolution of the number of infections in prostheses 
diagnosed in the USA between 1990 and 2004.
the complications, leading to prolonged hospitalization, 
repeated surgical interventions and even definitive loss 
of the implant, with shortening of the affected limb and 
significant permanent deformities(1,2). 
Risk factors and physiopathogenesis
The main risk factors predisposing towards infec-
tions in joint prostheses that are cited in the literature 
are: advanced age, malnutrition, obesity, diabetes mel-
litus, HIV infection at an advanced stage, presence of a 
distant focus of infection and a history of arthroscopy 
or infection in a previous arthroplasty. Patients with 
rheumatoid or psoriatic arthritis are also at greater risk 
of postoperative infection, which has been estimated to 
be three to eight times greater than for other patients. 
Prolonged duration of surgery (more than 150 minutes), 
blood transfusion and carrying out bilateral arthroplasty 
in a single operation are other factors relating to greater 
occurrence of infection. Any factor that delays the heal-
ing of the surgical wound, such as ischemic necrosis, he-
matoma, cellulitis and/or wound abscess, increases the 
risk of infection, since the deep tissues contiguous with 
the prosthesis do not have any local defense barriers(1,2,4). 
It is important to emphasize that the presence of the joint 
prosthesis leads to impairment of the function of the 
local granulocytes that accumulate around the implant: 
these become partially degranulated, with diminution 
of the production of dismutase superoxide and dam-
age to the defense capacity against bacteria, particularly 
against Staphylococcus aureus. Thus, the presence of 
the implant diminishes the size of the bacterial inocu-
lum needed for infection to take place, by more than 
100,000-fold(5).
Joint prostheses can become infected through three 
different routes: direct implantation, hematogenesis and 
reactivation of latent infection(2).
Penetration of microorganisms into the wound during 
surgery can occur through either endogenous or exog-
enous sources. Examples of such sources include the 
patient’s skin microbiota, the surgical team’s limbs, the 
environment or even contaminated implants.
Bacteremia from distant foci may cause contamina-
tion of the prosthesis through a hematogenic route. The 
primary foci most frequently reported in the worldwide 
literature are the respiratory tract, skin, urinary tract, 
dentition and gastrointestinal tract(2,5).
Gram-positive bacteria predominate in contamina-
tions of joint prostheses, especially Staphylococcus au-
reus and Staphylococcus epidermidis. However, infec-
tions caused by Gram-negative bacilli and fungi such 
as Candida sp are being reported with greater frequency 
all around the world(5).
Clinical presentations and diagnosis
Infections of joint prostheses present characteristic 
signs that can be divided into acute manifestations such 
as intense pain, high fever, toxemia, heat, redness and 
operative wound secretions, and chronic manifestations, 
namely progressive pain and formation of skin fistulas 
with drainage of purulent secretions, which in most cas-
es are without fever. The clinical presentation depends 
on the virulence of the etiological agent involved, the 
nature of the infected tissue and the infection acquisition 
route. Several classifications have been put forward to 
define the moment at which the contamination occurred 
and, through this, to establish the likely etiological agent 
involved and the best therapeutic strategy(1,2,5).
Nonspecific laboratory tests such as leukogram, eryth-
rocyte sedimentation rate, alpha-1-acid glycoprotein and 
Adapted from: Kurtz et al(3).
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implanted in the USA between 1990 and 2004.
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C-reactive protein may help in the diagnosis(2).
The radiographic abnormalities may be similar to 
those found in case of mechanical losses, and thus do 
not contribute towards diagnosing the infection. Ul-
trasound may be useful for locating deeper accumu-
lations and for guiding diagnostic puncture. Scinti-
graphic methods are considered to be more specific for 
the differential diagnosis, especially when techniques 
involving leukocytes or immunoglobulin labeled with
radioisotopes are used(2).
The definitive diagnosis for the infection is achieved 
through isolating the microorganism in cultures made 
from joint fluids obtained via puncture, secretions 
from the surgical wound and materials collected during
surgical debridement(1,2).
Preventive measures
Preoperative assessments on patients who are can-
didates for primary arthroplasty are of fundamental im-
portance for preventing postoperative infections, with 
the aims of identifying and treating quiescent foci of 
infection, stabilizing comorbidities and, when possible, 
reducing the use of immunosuppressant drugs. In addi-
tion to this care, the following are recommended(6): 
 ! Hospitalization close to the time of the operation;
 ! Rigorously controlled cleaning, sterilization and han-
dling of all surgical materials that are to be used; 
 ! Maintenance of adequate cleanliness and climate con-
trol conditions in the operating theater;
 ! Limited shaving, also performed close to the time of 
the operation, using depilatory creams and not cutting 
devices;
 ! Mechanical cleaning of the surgical site using anti-
septic solutions such as chlorhexidine; 
 ! Creation of special surgical environment with dif-
ferentiated gowning and, optionally, use of laminar 
flow;
 ! Adequate antibiotic prophylaxis, starting during the 
one-hour period preceding induction of anesthesia, 
and maintained for 24 hours;
 ! Control over body temperature and blood glucose lev-
els throughout the operative period;
 ! Shortest duration of operation possible with the ap-
propriate technique;
 ! Dressings carefully applied using an aseptic tech-
nique;
 ! Early mobilization of the patient during the postop-
erative period.
Treatment
Success in treating joint prosthesis infections de-
pends on extensive surgical debridement and adequate 
and effective antibiotic therapy(2,4). Infectious conditions 
that develop during the first year after the operation are 
considered to be hospital infections and, until receiv-
ing the results from cultures that were obtained in the 
surgical center, should be treated with antibiotics that 
act on the hospital microbiota of the hospital service 
where the surgery was performed. It is recommendable 
to start empirical antibiotic therapy at the time of induc-
ing anesthesia, which avoids the risks to patients result-
ing from surgical manipulation of the focus of infection 
without adequate coverage but does not interfere with 
any positive results from cultures on material collected 
during the operation. It is fundamentally important to 
have coverage for methicillin-resistant S. aureus, given 
the epidemiological importance of this agent in these 
infections(5). The total duration of antibiotic therapy 
ranges from six weeks to six months, and the treatment 
should be adjusted when necessary, based on the results 
from the cultures on the material that was collected(1,2,4,8).
Joint prosthesis infections that are manifested dur-
ing the first two to three weeks after the operation to 
implant the prosthesis can be treated initially with exten-
sive surgical cleaning combined with antibiotic therapy 
over a six-week period(8,9). Infections that are manifested 
after this period, caused by the formation of a biofilm 
and adherence of bacteria to the implanted material, 
should be treated with extensive surgical cleaning to-
gether with removal of the joint prosthesis, which can 
be replaced in either a single or a two-stage procedure. 
In such cases, the total duration of antibiotic administra-
tion is six months(7,10). The flow diagrams below sum-
marize the current recommendations for managing these
infections (Figures 3 and 4).
The highest therapeutic success rates, which can 
reach 93%, relate to removal of the infected prosthe-
sis combined with prolonged antibiotic therapy, which 
should be chosen based on the etiological agent that 
was isolated during the removal surgery, followed by 
implantation of a new prosthesis in a second surgi-
cal procedure, generally performed six to eight weeks 
later(7,10). Polymethyl methacrylate cement impregnated 
with gentamicin or tobramycin can be used for the re-
implantation of prostheses after infections. In cases of 
methicillin-resistant S. aureus, the cement can be im-
pregnated with vancomycin.
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Joint prosthesis infections have been increasing 
worldwide in parallel with the growth in the numbers 
of procedures carried out. These are worrying events 
in any of their presentation, not only because of the 
potential seriousness but also because of the high cost 
to patients and to the entire healthcare system. In indi-
cating joint prosthesis implantation surgery, it is fun-
damentally important to always implement actions to 
prevent such infections, with careful observation of all 
of the factors that might contribute towards increas-
ing the risk of this complication. Once the infection 
has become established, rapid clinical and laboratory 
diagnosis, associated with adequate management, will 
especially contribute towards increasing the possibility 
of definitive resolution of the process.
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